Skip to main content

stock

TMCI · TREACE MEDICAL CONCEPTS, INC.

What TREACE MEDICAL CONCEPTS, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live TMCI price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on TMCI.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
65,034,552 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
79.5%
Operating
-26.2%
Net
-29.0%

Returns

ROE
-87.9%
ROA
-32.9%

Health

Current ratio
2.9x
Debt/equity
0.8x

Deep value

NCAV
$7.14M
NCAV per share
$0.11
Price/NCAV
Locked
NNWC
-$59.39M
NNWC per share
-$0.91
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$45.38M$35.61M-$14.96M-$15.87M
10-Q filed 2026-08-07
2026-03-31$47.20M$37.41M-$17.17M-$17.96M
10-Q filed 2026-08-07
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$62.52M$50.40M-$5.92M-$9.39M
DEF 14A filed 2026-04-06
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$50.21M$39.71M-$15.68M-$16.29M
10-Q filed 2025-11-06
2025-06-30$47.39M$37.75M-$16.97M-$17.40M
10-Q filed 2026-08-07
2025-03-31$52.57M$41.89M-$15.58M-$15.92M
10-Q filed 2026-08-07
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$68.71M$55.48M-$204,000-$501,000
DEF 14A filed 2026-04-06
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$45.09M$36.13M-$15.13M-$15.36M
10-Q filed 2025-11-06
Assets
$181.06M
Equity
$67.74M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$212.69M-$54.15M-$59.00M-$29.49M
2024-12-31$209.36M-$55.69M-$55.74M-$48.76M
2023-12-31$187.12M-$51.43M-$50.00M-$46.03M
2022-12-31$141.84M-$34.84M-$43.00M-$45.49M
2021-12-31$94.42M-$16.51M-$20.55M-$19.90M
2020-12-31$57.37M$855,000-$3.67M-$5.56M
2019-12-31$39.42M-$3.54M-$4.26M-$8.88M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named TMCI, and the market events around them.

Sign in to see this

Board

The TMCI board could not be loaded.

Retry the TMCI board

nakagai

Signals on TMCI come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the TMCI board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

TREACE MEDICAL CONCEPTS, INC. (TMCI): SEC filings, financials and insider trades · Nakagai